1 CURRICULUM VITAE – DANIEL ABRAMOWICZ ... - Oxford Journals

86. M. JADOUL, C. DODÉ, J.P. COSYNS, D. ABRAMOWICZ, B. GEORGES,
M. DELPECH, Y. PIRSON.
Autosomal dominant periodic fever with AA amyloidosis: novel mutation in Tumor
Necrosis Factor Receptor 1 gene. Rapid Communication.
Kidney Int. 2001 May;59(5):1677-82 (IF : 4,371).
87. M. SURQUIN, A. LE MOINE, V. FLAMAND, N. NAGY, K. ROMBAUT,
F-X. DEMOOR, P. STORDEUR, I. SALMON, J-C. GUÉRY, M. GOLDMAN,
D. ABRAMOWICZ
Skin graft rejection elicited by B2 microglobulin as a minor transplantation antigen
involves multiple effector pathways: role of Fas-Fas-ligand interactions and Th-2-
dependent eosinophil infiltrates.
J. Immunol, 2002; 169:500-506 (IF : 6,834)
88. H LOUIS, A LE MOINE, V FLAMAND, N NAGY, E QUERTINMONT, F PAULART,
D ABRAMOWICZ, O LE MOINE, M GOLDMAN, J DEVIERE
Role of NKT cell-derived IL-5 and eosinophils in experimental acute hepatitis
Gastro-enterology, 2002; 122:2001-2010 (IF:13.092).
89. F. HOUSSIAU, C VASCONCELOS , D D’CRUZ , G-D SEBASTIANI, E DE RAMON,
M-G DANIELI, D ABRAMOWICZ, D BLOCKMANS, A MATHIEU, H
DIREKENELI, M GALEAZZI, A GUL, Y LEVY, P PETERA, R POPOVIC, R
PETROVIC, R SINICO, R CATTANEO, J FONT, G DEPRESSEUX, J-P COSYNS,
AND R CERVERA for the Euro-Lupus Nephritis Trial Group
Immunosuppressive therapy in lupus nephritis : a randomised trial of low-dose versus
high-dose intravenous cyclophosphamide.The Euro-Lupus Nephritis Trial
Arthritis and Rheumatism, 2002; 46: 2121-2131 (IF : 6,841).
90. A LE MOINE, V FLAMAND, A DE LAVAREILLE, F PAULART, S BUONOCORE,
M-L VANDERHAEGEN, N NAGY, C HABRAN, R KISS, D ABRAMOWICZ,
M GOLDMAN
Experimental hypereosinphilic syndrome induced by neonatal injection of cells disparate
at a single class II alloantigen: critical role of IL4
European Journal of Immunology, Jan;32(1):174-81, 2002 (IF : 5,240).
91. D. ABRAMOWICZ, D MANAS, M LEO, Y VANRENTERGHEM, D DEL
CASTILLO, P WIJNGAARD, S FUNG
Cyclosporin withdrawal from a mycophenolate mofetil-containing immunosuppressive
19